We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Collaboration will give Pierre Fabre the option to enter into exclusive negotiations to license global rights for the program in selected skin cancer conditions.